2.10. Quinolinic acid striatal lesions and neural transplantation

SP S.V. Precious
CK C.M. Kelly
AR A.E. Reddington
NV N.N. Vinh
RS R.C. Stickland
VP V. Pekarik
CS C. Scherf
RJ R. Jeyasingham
JG J. Glasbey
MH M. Holeiter
LJ L. Jones
MT M.V. Taylor
AR A.E. Rosser
request Request a Protocol
ask Ask a question
Favorite

Quinolinic acid is a relatively selective MSN toxin, sparing most of the interneuron populations (Schwarcz and Kohler, 1983, Schwarcz et al., 1983, Beal et al., 1986). Animals (CD1 mice and Sprague-Dawley rats) received unilateral injection of 45 nmol quinolinic acid into the right striatum, and transplantation was carried out at 10–14 days post-quinolinic acid lesion as per Kelly et al. (2007). For mouse E14 WGE transplants into the host adult mouse lesioned striatum, 250,000 cells were resuspended in 2 μL and stereotactically injected over 2 min. For human WGE transplants into the host adult rat lesioned striatum, 500,000 cells were resuspended in 2 μL and stereotactically injected over 2 min.

Animals were housed in a natural light-dark cycle with access to food and water ad libitum. All surgery was performed under isofluorane anaesthesia and post-surgery animals were recovered in a warmed recovery chamber and received analgesia by Metacam (Boehringer Ingelheim). All animals were perfused transcardially and fixed using 1.5% paraformaldehyde solution before the brains were removed, post-fixed overnight and transferred to 25% sucrose for cryoprotection. Brains were sectioned at 40 μm on a freezing-stage microtome and sections were stored for subsequent histological analysis.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A